论文信息 - Prognostic and Predictive Gene Expression Profiling (GEP) Markers Confirmed in Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Treated Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) - 字舞流文

Prognostic and Predictive Gene Expression Profiling (GEP) Markers Confirmed in Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Treated Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts)

K. Griffith | A. Jakubowiak | R. Vij | M. V. Vliet | E. H. Beers | L. Bosman | Malathi Kandarpa | D. Dytfeld | B. Dumee | S. Rosebeck | Mattina M Alonge | J. Jasielec | Kathryn McDonnell | L. DeBest